JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Abstract Freely available
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mast, S. T.
Right arrow Articles by Borges-Neto, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mast, S. T.
Right arrow Articles by Borges-Neto, S.

Incremental Prognostic Value of RNA Ejection Fraction Measurements During Pharmacologic Stress Testing: A Comparison with Clinical and Perfusion Variables

Steven T. Mast, Linda K. Shaw, Gregory C. Ravizzini, Marianna Chambless, Peter Joski, R. Edward Coleman and Salvador Borges-Neto

Division of Cardiology, Department of Internal Medicine, and Division of Nuclear Medicine, Department of Radiology, Duke University Medical Center and Health Systems, Durham, North Carolina



View larger version (14K):

[in a new window]
  		FIGURE 1. Unadjusted Kaplan-Meier survival (A) and event-free survival (B) curves stratified by ejection fraction (EF) > 45% or <= 45%.

 


View larger version (13K):

[in a new window]
  		FIGURE 2. Adjusted (for clinical and perfusion results) Kaplan-Meier survival (A) and event-free survival (B) curves stratified by ejection fraction (EF) > 45% or <= 45%.

 


View larger version (20K):

[in a new window]
  		FIGURE 3. Incremental prognostic value of clinical information (clinical index), perfusion imaging (SSS), and RNA (ejection fraction) considered in hierarchical order for prediction of death (A) and death/MI composite endpoint (B). LR = likelihood ratio.

 


View larger version (20K):

[in a new window]
  		FIGURE 4. Independent and relative prognostic power of RNA ejection fraction over clinical (clinical index) and perfusion information (SSS) for death (A) and death/MI composite endpoint (B). Once clinical and ejection fraction information was known, no further improvement in {chi}2 statistics was obtained with addition of perfusion information. LR = likelihood ratio.

 




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2001 by the Society of Nuclear Medicine.